02359 WUXI APPTEC
- 42.600
- +2.800+7.04%
WUXI APPTEC News
Yao Ming Kangde (02359) spent about 2.046,900 yuan to buy back 432,200 A shares on May 13
According to the Zhitong Finance App, Yao Ming Kangde (02359) issued an announcement to repurchase 432,200 A-share shares with an investment of approximately RMB 2.046,900 (RMB, same below) on May 13, 2024, at a repurchase price of 45.8-48.15 yuan per share.
Intraday Overview | Tech Index rose more than 1%, and TechNet stocks were trending strongly. Bilibili rose more than 6%; Tencent Music rose more than 9% after its performance
Technology Network stocks rose collectively, with Bilibili up more than 6%, Kuaishou and Xiaomi Group up more than 3%; auto stocks improved, Great Wall Motor rose more than 7%, NIO rose nearly 6%, and Zero Sports Auto rose nearly 5%.
The Hong Kong stock CXO concept market surged higher at the beginning, and Yao Ming Kangde rose more than 6%
The Hong Kong stock CXO concept market initially surged higher, with Yao Ming Kangde rising more than 6%, Kanglong Chemical and Kingsry Biotech rising by more than 5%, and Pharmaceutical Biotech and Zhaoyan New Pharmaceutical.
Express News | Galaxy Securities: Judging from the pace of the industry's revenue growth rate, the first quarter of 2024 is expected to be the lowest point in the pharmaceutical industry in the whole year
The medical news is huge! Will Pharmacokinetics usher in a turning point? US pharmaceutical company contract exemption or extension for 8 years
Industry insiders believe that 8 years is enough time for relevant companies to adapt, and the implementation of this greatest uncertainty can also have a positive impact on related companies.
J.P. Morgan sold 726,700 H shares of Yao Ming Kangde (02359.HK), worth approximately HK$27.391 million
On May 13, it was reported that according to documents disclosed by the Hong Kong Stock Exchange on May 13, JPMorgan Chase & Co. (JPMorgan Chase & Co.) sold $726,700 H-share shares worth about HK$27.4841 on the market and HK$37.4881 per share on the market on May 7. After the sale, J.P. Morgan Chase's latest shareholding was 30.7941 million shares, and the good position ratio dropped from 8.14% to 7.95%. Image source: What is the Stock Exchange's equity disclosure
A quick look at the Hong Kong market | The three major indices have risen one after another. Technology Network stocks and power stocks are popular. Bilibili has risen more than 6%, and Huadian International has risen nearly 8%
Biotech stocks had mixed ups and downs. Pharmaceutical and Ming Union fell%, and Jinxin Fertility rose%; shipping stocks rose, with Dongfang Overseas International, COSCO Marine Control, and COSCO Marine Energy up nearly 6%.
Intraday quick overview | The Science Index rose more than 1% to reach the 4,000 mark; port transport stocks were strong, and COSCO Marine Control rose more than 6%
Water stocks soared across the board. China Water Services rose more than 9%, Beijing Water Group rose more than 8%; high-speed rail infrastructure stocks collectively rallied, CRRC rose more than 9%, and Times Electric rose nearly 7%.
“Pharmacovigilance”, open high and walk low
Glonghui, May 13 | Hong Kong stocks opened high and went low, and Pharmaceutical Kant erased gains. Previously, it had risen by more than 15%; Yao Ming Biotech fell more than 7%, and had previously risen by more than 6%.
Shares of Yao Ming Kang De and Pharmaceutical Biotech rose
Shares of Yao Ming Kang De and Pharmaceutical Biotech rose
CRO concept stocks opened and surged. Baihua Pharmaceuticals rose and stopped. Wanbang Pharmaceuticals rose more than 17%, Pharmaceutical Kangde rose more than 8%, and Kanglong Chemical, Gloria Ying, and Tiger Pharmaceuticals all opened higher.
CRO concept stocks opened and surged. Baihua Pharmaceuticals rose and stopped. Wanbang Pharmaceuticals rose more than 17%, Pharmaceutical Kangde rose more than 8%, and Kanglong Chemical, Gloria Ying, and Tiger Pharmaceuticals all opened higher.
Hong Kong stocks opened, the Hang Seng Index fell 0.31%, and the Science Index opened down 0.94%. Pharmaceutical stocks generally rose, Pharma Ming Kangde rose nearly 15%, and Pharmaceutical Biotech rose nearly 8%.
Hong Kong stocks opened, the Hang Seng Index fell 0.31%, and the Science Index opened down 0.94%. Pharmaceutical stocks generally rose, Pharma Ming Kangde rose nearly 15%, and Pharmaceutical Biotech rose nearly 8%.
Investors Aren't Buying WuXi AppTec Co., Ltd.'s (SHSE:603259) Earnings
WuXi AppTec Co., Ltd.'s (SHSE:603259) price-to-earnings (or "P/E") ratio of 13.9x might make it look like a strong buy right now compared to the market in China, where around half of the companies hav
Yao Ming Kang De (603259): Maintaining the same guidelines throughout the year and optimistic about future long-term development
Event: The company released its 2024 quarterly report. 24Q1 achieved operating income of 7.982 billion yuan, a year-on-year decrease of 10.95%. Excluding COVID-19 projects, a year-on-year decrease of 1.8%; realized net profit to mother of 1,942 billion yuan, same
Yao Ming Kangde (02359.HK) spent 2005 million yuan to buy back 447,000 A shares on May 10
On May 10, Ge Longhui (02359.HK) issued an announcement to buy back 447,000 A-shares at a cost of RMB 2005 million on May 10, 2024.
Xiaomo increased its holdings of Pharmaceutical Kangde (02359.HK) by about 347,800 shares at a price of about HK$36.64 per share
According to the latest data from the Hong Kong Stock Exchange, on May 3, Xiaomo increased its holdings of Pharmaceutical Kangde (02359.HK) by 3478.41 million shares, with an average price of HK$36.6444 per share, for a total amount of about HK$127.66,400. After the increase in holdings, the latest number of shares held was approximately 31.18,500 shares, and the latest shareholding ratio was 8.03%.
Yao Ming Kangde (02359.HK) received 347,800 shares from J.P. Morgan
Glonghui, May 10 | According to the latest equity disclosure data on the Stock Exchange, on May 3, 2024, Yao Ming Kangde (02359.HK) obtained JPMorgan Chase & Co. increased its position by 347,800 shares at an average price of HK$36.6444 per share, involving approximately HK$12.75 million. After the increase in holdings, JPMorgan Chase & Co.'s latest number of open positions was 31.18,500 shares, and the holding ratio increased from 7.94% to 8.03%.
WUXI APPTEC To Go Ex-Dividend On June 17th, 2024 With 1.08424 HKD Dividend Per Share
May 10th - $WUXI APPTEC(02359.HK)$ is trading ex-dividend on June 17th, 2024. Shareholders of record on June 18th, 2024 will receive 1.08424 HKD dividend per share on June 30th, 2024. The ex-divid
Yao Ming Kangde (02359) plans to pay a final dividend of 9.8336 yuan for every 10 shares
Yao Ming Kangde (02359) announced that the company plans to pay a final dividend of 9.8336 yuan for every 10 shares.
WUXI APPTEC: NOTICE OF THE ANNUAL GENERAL MEETING OF 2023
Analysis
Price Target
No Data
